Wednesday, 8 February 2012

Angel biotechnology has signed three new manufacturing contracts with Materia Medica Holding, worth £4.5m. Angel will start the projects at its Edinburgh facility before transferring later this year to its refurbished, larger site at Cramlington, UK.
The Herald

No comments:

Fine

The FINE blog keeps you up-to-date on the pharmaceutical fine chemical and custom manufacturing sector. The weekly FINE Newsletter gives senior pharmaceutical fine chemical and custom manufacturing leaders a weekly summary of the key news stories and trends for the sector. The FINE Newsletter and blog focus on coverage of companies in the pharmaceutical fine chemical custom manufacturing sector, without forgetting key news from their customers in the pharma industry.